KFDA to enhance review efficiency for drug safety and efficacy.

KFDA plans to have an explanatory meeting at the auditorium of the Disease Control Office at 2 p.m. on March 18 to improve the drug safety and efficacy review, to satisfy conveniencies to the civilian needs and to keep more efficient and transparent in the review works

The meeting has been realized after the reorganization in February with which the drug review conducted by two separated di...